Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding the closing of Altimmunes anticipated public offering
What you need to know, Harvard Health Publishing (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
While many of the side effects are common and mild, such as nausea, vomiting, and diarrhea, some are more severe resulting in long-term health problems
A Certificate of Analysis (CoA) is available upon request for each batch
On top of that, probiotics need to survive and thrive